Look Under The Hood: FTKI Has 27% Upside
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 20 2025
0mins
Source: NASDAQ.COM
ETF Analysis: The First Trust Small Cap BuyWrite Income ETF (FTKI) has an implied analyst target price of $24.35 per unit, indicating a potential upside of 27.07% from its current trading price of $19.16.
Stock Performance Insights: Notable underlying holdings such as Teekay Tankers Ltd, Catalyst Pharmaceuticals Inc, and Cadre Holdings Inc show significant upside potential based on analyst targets, raising questions about the validity and optimism of these projections.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CDRE?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CDRE
Wall Street analysts forecast CDRE stock price to rise
3 Analyst Rating
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 29.440
Low
50.00
Averages
52.67
High
55.00
Current: 29.440
Low
50.00
Averages
52.67
High
55.00
About CDRE
Cadre Holdings, Inc. is engaged in the manufacturing and distribution of safety products. The Company's equipment provides protection to allow users to safely perform their duties and protect those around them in hazardous or life-threatening situations. Its core products include body armor, explosive ordnance disposal equipment, duty gear and nuclear safety products. Its principal body armor product offerings include concealable, corrections and tactical armor, which provide varying levels of protection against ballistic or sharp instrument threats. It offers an engineered portfolio of critical operator survival suits, blast sensors, accessories and vehicle blast attenuation seats for bomb safety technicians, among others. Its engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Its key brands include Safariland and Med-Eng, among others.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Insider Selling Warning: Warren B. Kanders, CEO of Cadre Holdings, sold 75,000 shares for approximately $2.07 million, marking his sixth sale in the past year and raising concerns about investor confidence as he has unloaded 1.9 million shares since November 2025.
- Shareholding Structure Change: Post-transaction, Kanders retains over 10 million shares indirectly, and while this sale is below his historical average, it may prompt scrutiny regarding his future trading intentions and market reactions.
- Poor Market Performance: Cadre Holdings has experienced a 9.5% decline in stock price over the past year, and Kanders' selling behavior could be interpreted as a sign of concern regarding the company's future performance, necessitating a reassessment of investment strategies by shareholders.
- Sufficient Liquidity: Despite the stock sale, Kanders received over $4 million in cash compensation from the company, indicating he does not lack liquidity, which may further fuel speculation about the motivations behind his selling activities.
See More
- Insider Selling Warning: Cadre Holdings CEO and Chairman Warren B. Kanders sold 75,000 shares on June 18 and 22, 2026, at an average price of $27.57 per share, totaling over $2.07 million, reducing his ownership to 10.97 million shares, which raises concerns about the company's outlook.
- Frequent Sales Raise Flags: Kanders has sold 1.9 million shares over six transactions in the past year, and while insider sales do not always indicate a price drop, CDRE shares have declined after each sale, prompting investors to reassess their investment thesis.
- Cash Compensation Context: In 2025, Kanders received over $4 million in cash compensation, indicating he has sufficient liquidity; however, his selling behavior may reflect a cautious stance on future market performance, which investors should monitor closely.
- Poor Market Performance: Cadre Holdings has underperformed in the market, failing to make The Motley Fool Stock Advisor's list of top ten stocks, suggesting that investors should thoroughly analyze the company's fundamentals and market prospects before making investment decisions.
See More
- Contract Awarded: Cadre Holdings' subsidiary Safariland has been selected as the ballistic panel provider for the FBI, responsible for supplying the SX HP ballistic panel, marking a significant expansion in the company's federal law enforcement market.
- Contract Value: The five-year contract is valued at $61 million and falls under an indefinite delivery/indefinite quantity agreement, reflecting the government's ongoing demand for high-performance safety equipment.
- Product Integration: Safariland's SX HP ballistic panel will be integrated into Predictive Ballistics LLC's Overt Armor Kit, enhancing the system's protective capabilities and meeting law enforcement agencies' requirements for high-quality gear.
- Market Strategy: The contract win not only expands Cadre's federal law enforcement business pipeline but also supports its strategy of supplying mission-critical safety equipment to government customers, further solidifying its market position.
See More
- Significant Contract Value: Cadre Holdings' subsidiary Safariland has been selected as the ballistic panel provider for a five-year, $61 million contract with the FBI, underscoring its strong competitive position and market demand in the safety equipment sector.
- Product Innovation Recognition: The Safariland SX™ HP ballistic panel was chosen over 11 competing products after a rigorous evaluation, demonstrating Cadre's ongoing investment in next-generation protective equipment and technological innovation.
- Growing Market Demand: This contract reflects Cadre's growth potential in federal law enforcement business, aligning with the company's strategy to develop highly engineered, mission-critical products that meet stringent market standards.
- Long-Term Growth Outlook: Federal agency contracts typically feature multi-year terms and stable demand driven by equipment modernization cycles, positioning Cadre's products to support sustained growth in the future.
See More
- Significant Revenue Growth: Cadre reported Q1 2026 revenue of $155.4 million, a 19.5% year-over-year increase that surpassed analyst expectations of $155 million, indicating strong ongoing demand in law enforcement, military, and nuclear safety products.
- Profitability Improvement: The company’s adjusted EPS of $0.18 exceeded analyst estimates of $0.09 by 98.7%, reflecting robust performance in core offerings, although overall operating margin declined.
- Record Backlog: Cadre exited the quarter with a record $355 million in orders backlog, signaling strong future demand, particularly driven by contracts like the General Dynamics deal and contributions from the TIER Tactical acquisition.
- Accelerated Acquisition Strategy: The successful acquisitions of TIER Tactical and Alien Gear Holsters are expected to enhance sales and margins through product synergies and improved market positioning, strengthening Cadre's competitive edge in public safety and nuclear markets.
See More
- Significant Sales Growth: Cadre Holdings reported Q1 2026 net sales of $155.4 million, reflecting a 19% year-over-year increase, indicating strong market performance and positioning the company to achieve its full-year sales target of $736 million to $758 million.
- Record Backlog: The company ended Q1 with a record backlog of $355 million, which included an organic increase of $108 million from Q4 to Q1, suggesting robust future production capacity and market demand.
- Ongoing Acquisition Strategy: Cadre has deployed over $400 million in targeted M&A since the start of 2024, including the acquisition of TYR Tactical in January and Alien Gear Holsters in April, which are expected to enhance the product range and increase customer wallet share.
- Improving Margin Expectations: Despite facing some market challenges, management anticipates that adjusted EBITDA margins will reach 17.5% in 2026 as sales grow and product mix improves, providing support for the company's future financial health.
See More









